Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Spyglass Capital Management. This analysis is provided for institutional research purposes only and is not investment advice.
"The Spyglass Growth Strategy generated a 12.22% net return in Q3 2025, significantly outperforming benchmarks through strong stock selection. Maintaining a highly concentrated 25-position portfolio, the manager capitalizes on secular megatrends like AI, automation, and genomics, while strictly adhering to a valuation framework that prompts exits once targets are achieved."
Spyglass Capital Management is anchored on the core philosophy that true value investing entails purchasing high-quality growth leaders and emerging industry giants at prices representing significant discounts to their calculated present values based on future discounted cash flows. In the third quarter of 2025, the Spyglass Growth Strategy delivered a strong net return of 12.22%, dramatically outperforming key benchmarks such as the Bloomberg Midcap Growth Index and S&P 500. Portfolio company performance was driven by stellar earnings growth, with holdings averaging 48% year-over-year EPS expansion. Principal contributors included AppLovin, MongoDB, and Medpace. While optimistic, the manager highlights macro challenges such as slowing labor markets and elevated valuations in certain AI-affiliated sectors. To manage risk, Spyglass maintains a strict, concentrated portfolio of exactly 25 names, executing disciplined process-driven exits when calculated intrinsic value targets are reached. Strategic portfolio actions this quarter included adding Samsara, Ascendis Pharma, Loar Holdings, and Fair Isaac Corporation, alongside full exits from Astera Labs, Veeva Systems, Robinhood, and CyberArk following substantial run-ups or acquisition events.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
Assigned 0.70 because Spyglass maintains a concentrated, fixed 25-stock portfolio with high-conviction positions. The manager has explicit sell disciplines and sizes names with clear present value calculations, but the relative diversification (25 names) places it in the moderate-to-high territory rather than hyper-concentrated.
Growth Outlook
Assigned 0.75 reflecting a constructive outlook as the broader market reaches new highs. The manager is optimistic about secular megatrends and robust corporate earnings growth, though they remain cautious of bubble valuations in certain AI sub-sectors.
Risk Appetite
Assigned 0.70 because the fund remains structurally growth-focused and fully invested in a variety of high-growth sectors. They have selectively rotated capital into new high-upside ideas rather than retreating to cash.
Capital Deployment
Assigned 0.60 because the fund operates under a strict 'one-in, one-out' 25-position policy. Consequently, capital deployment is characterized by high-velocity rotation of existing resources rather than massive net cash drawdowns.
Forward Guidance
Assigned 0.65 as the manager shows a balanced action bias, maintaining their strict 25-position limit by swapping out fully-valued names like Veeva and Astera Labs to fund new, more asymmetric entries like Samsara and FICO.
Language Signal
Assigned 0.75 due to highly optimistic descriptions of portfolio holdings' growth rates (48% EPS CAGR) and secular megatrends, offset marginally by defensive commentary on high AI valuations and individual stock execution reviews.
Perceived Risk
Assigned 0.50 to reflect standard risk concerns including interest rate shifts, macroeconomic software demand softness, and pockets of stock market overvaluation, without any signs of severe systemic panic.
Opportunity Density
Assigned 0.75 as the manager notes that despite high broad market valuations, their research continues to identify abundant, mispriced high-growth targets, allowing them to easily deploy capital into four new opportunities.
Time Horizon
Assigned 0.75, representing a strong 3-to-5-year multi-year outlook. The manager analyzes products like Yorvipath over a 3-5 year blockbuster horizon and views Loar's aerospace components through a 30-50 year service lifecycle.
